Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protege EverfLex NitInol STent SYstem II

NCT00530712 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

NCT NCT00530712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00530712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protege EverfLex NitInol STent SYstem II
Lead sponsor
Medtronic Endovascular
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2007
Completion date
July 31, 2013
Enrollment
287 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

claudication, peripheral vascular diseases